Which component of sulphasalazine is active in rheumatoid arthritis?
- 25 May 1985
- Vol. 290 (6481) , 1535-1538
- https://doi.org/10.1136/bmj.290.6481.1535
Abstract
Sulphasalazine is known to be effective as a second line agent in the treatment of rheumatoid arthritis. The two chemical constituents of sulphasalazine (sulphapyridine and 5-aminosalicylic acid) were assessed separately in the treatment of rheumatoid arthritis. Over 24 weeks sulphapyridine showed a pronounced second line effect comparable with sulphasalazine and with a similar toxicity profile, whereas 5-aminosalicylic acid showed only a weak first line effect. Thus sulphapyridine appears to be the active moiety responsible for the second line effect of sulphasalazine in rheumatoid arthritis. The efficacy of the antibacterial component of sulphasalazine yet again permits speculation about the role of a bacterial pathogen in the aetiopathogenesis of rheumatoid disease.This publication has 12 references indexed in Scilit:
- A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question?Annals of the Rheumatic Diseases, 1985
- SULPHASALAZINE: A ‘NEW’ ANTIRHEUMATIC DRUGRheumatology, 1984
- Malaria vaccination: two steps forward, one backward.BMJ, 1983
- A human model screening system for the detection of specific antirheumatic activitySeminars in Arthritis and Rheumatism, 1982
- A BIOCHEMICAL ASSESSMENT OF SULPHASALAZINE IN RHEUMATOID-ARTHRITIS1982
- Prenatal development of lumbar intervertebral articulation.1982
- Sulphasalazine in rheumatoid arthritis.BMJ, 1980
- Clinical Pharmacokinetics of SulphasalazineClinical Pharmacokinetics, 1976
- Salicylazosulfapyridine (salazopyrin or azopyrin) in rheumatoid arthritis and experimental polyarthritis.1950
- Salazopyrin in the Treatment of Rheumatoid ArthritisAnnals of the Rheumatic Diseases, 1949